Gene polymorphism linked to cardiac morbidity, mortality

December 19, 2013
Gene polymorphism linked to cardiac morbidity, mortality

(HealthDay)—The functional nonsynonymous single nucleotide polymorphism (rs6318) of the 5HTR2C gene is associated with increased risk of cardiovascular disease mortality and morbidity, according to a study published online Dec. 18 in PLOS ONE.

Beverly H. Brummett, Ph.D., from the Duke University Medical Center in Durham, N.C., and colleagues investigated allelic variation in rs6318 as a predictor of severity and of a composite end point of all-cause mortality or (MI) in a cohort of 6,126 Caucasian participants (65.9 percent males).

During a median follow-up of 5.3 years, the researchers identified 1,769 events (1,544 deaths and 225 MIs). In unadjusted models, males hemizygous for Ser23 C and females homozygous for Ser23 C had a significantly increased risk for the composite end point, compared with Cys23 G carriers (hazard ratio, 1.47; P = 0.0008). In males and females, the rs6318 genotype was not associated with , diabetes, hypertension, dyslipidemia, smoking history, number of diseased coronary arteries, or left ventricular ejection fraction, after adjustment for age. The estimate for the two Ser23 C groups was modestly attenuated after adjustment for these covariates, but remained statistically significant (hazard ratio, 1.38; P = 0.005).

"These findings suggest that this functional polymorphism of the 5HTR2C gene is associated with increased risk for mortality and morbidity, but this association is apparently not explained by the association of rs6318 with traditional risk factors or conventional markers of atherosclerotic disease," the authors write.

Explore further: For under-75s, living alone tied to higher mortality risk

More information: Full Text

Related Stories

Factors in long-term HCV morbidity, mortality analyzed

November 6, 2013

(HealthDay)—For patients with hepatitis C virus (HCV), achieving an undetectable viral load correlates with reductions in the risk of clinical end points and death, according to a study published online Nov. 5 in JAMA Internal ...

Hyperglycemia may increase myocardial infarction mortality

November 6, 2013

(HealthDay)—Hyperglycemia is common among patients presenting with myocardial infarction and is associated with a higher risk of death, according to a study published in the Nov. 1 issue of The American Journal of Cardiology.

Oral multivitamin, multimineral safe, not effective after MI

December 17, 2013

(HealthDay)—For older patients with a history of myocardial infarction (MI), a high-dose oral multivitamin and multimineral mixture is safe, but does not significantly reduce cardiovascular events, according to a study ...

Stress reaction gene linked to death, heart attacks

December 18, 2013

A genetic trait known to make some people especially sensitive to stress also appears to be responsible for a 38 percent increased risk of heart attack or death in patients with heart disease, scientists at Duke Medicine ...

Recommended for you

No new heart muscle cells in mice after the newborn period

November 5, 2015

A new study from Sweden's Karolinska Institutet shows that new heart muscle cells in mice are mainly formed directly after birth. After the neonatal period the number of heart muscle cells does not change, and A new study ...

Nanotechnology could spur new heart treatment

October 29, 2015

A new nanoparticle developed by University of Michigan researchers could be the key to a targeted therapy for cardiac arrhythmia, a condition that causes the heart to beat erratically and can lead to heart attack and stroke.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.